A biocompatible built-in stent material

A technology of prosthetic materials and compositions, applied to intravascular stent materials and metals, can solve the problems of loss of EC function, vascular stenosis, poor clinical effect of endothelial inoculation, etc., and achieve the effect of inhibiting restenosis and avoiding restenosis

Active Publication Date: 2020-05-12
CHINABRIDGE (SHENZHEN) MEDICAL TECH CO LTD
View PDF14 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Synthetic grafts have also been inoculated with endothelial cells, but the clinical outcome of endothelial inoculation is generally poor, most likely due to nonadhesive properties of the cells to the graft and / or loss of EC function due to ex vivo manipulation
CN105327399 provides a method for constructing artificial blood vessels, which introduces prokaryotic system expression vectors with hydrophilic and negatively charged polypeptide genes and cell adhesion-promoting polypeptide genes on the surface (Journal of DonghuaUniversity (English Edition), 2012, 29:26 -29; Bio-Medical Materials and Engineering, 2014, 24:2057–2064), which improves surface hydrophilicity and negative charge, increases endothelialization potential, and is beneficial to tissue healing and anticoagulation, but this technology is suitable for constructing artificial blood vessels, The materials used include polyester. Obviously, for the field of vascular stents that need to be degraded after vascular stenosis treatment, this material has natural non-biocompatibility and cannot provide the mechanical support properties required by vascular stents. At the same time, as mentioned above As mentioned above, if endothelial cell proliferation cannot maintain homeostasis, it will lead to the formation of vascular restenosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A biocompatible built-in stent material
  • A biocompatible built-in stent material
  • A biocompatible built-in stent material

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Fabrication of prostheses (preferably endovascular stents) with microcavities and short peptide coatings

[0052] Step 1: Obtain the matrix material of the prosthesis, which can degrade the tubular material of pure iron, and make it have holes connecting the inside and outside on the surface;

[0053] Step 2: Using laser engraving technology, obtain a microcavity in the thickness direction of the above-mentioned hole that runs through the prosthesis; the microcavity has a hemispherical profile, its diameter is 30 μm, and the depth of its bottom is the diameter of the hole 1 / 3 of that, and the total number of microcavities is 30;

[0054] Step 3: Using conventional techniques, obtain a composition in the form of microcapsules, said composition comprising gelatin as a "shell" and histidine-chelated iron as a "core", wherein the histidine-chelated iron is contained in the composition The weight content in is 0.5%, and the degradation period of described gelatin is about 7...

Embodiment 2

[0059] Fabrication of prostheses (preferably endovascular stents) with microcavities and short peptide coatings

[0060] The preparation process is the same as in Example 1, the difference is that: the matrix material used in step 1 is degradable polycaprolactone; the diameter of the microcavity in step 2 is 50 μm, and the depth dimension of the bottom is 1 / 4 of the diameter of the hole, The total number of microcavities is 40; the shell described in step 3 is chitosan, the degradation cycle is about 1 week, and the core is cysteine ​​chelated iron, wherein the weight content of the core in the composition is 0.8%; The loading amount in step 4 was 8 μg.

Embodiment 3

[0062] Fabrication of prostheses (preferably endovascular stents) with microcavities and short peptide coatings

[0063] The preparation process is the same as in Example 1, the difference is that: the base material used in step 1 is degradable pure magnesium; the diameter of the microcavity in step 2 is 100 μm, and the depth dimension of the bottom is 1 / 5 of the diameter of the hole, and the microcavity The total number is 60; the shell in step 3 is collagen, and the degradation period is about 2 weeks, and the core is cysteine ​​chelated iron, wherein the weight content of the core in the composition is 1.5%; in step 4, the load The amount is 10 μg; the sequences of the two short peptides in step 5 are sequence 3 and sequence 4 described above, respectively.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

The invention relates to a biocompatible endoprosthesis material, which comprises a matrix, a microcavity, a composition and short-peptide layers, wherein the material of the matrix is biodegradable in vivo tissues, the matrix is in a tubular shape and is provided with an inner tubular surface and an outer tubular surface, the inner surface forms a channel for a tissue fluid such as blood to pass through, and a structure for communicating the inner surface and the outer surface is arranged on the surface; the microcavity is obtained when a communicating structure is located in a cross-section direction, perpendicular to an axial direction, of a matrix body; the microcavity is located in a thickness direction of a hole; a plane of an opening of the microcavity is basically perpendicular to an inner surface and an outer surface of a tubular-shaped stent; the composition is loaded in the microcavity and can be degraded to release Fe<3+>; the short-peptide layers are located on the inner surface and the outer surface of the matrix material; short peptides can be self-assembled to form hydrogel; the hydrogel formed after the short peptides are self-assembled can be specifically favorable to climbing and covering of endothelial cells and regeneration of endodermis; a prosthesis can provide required biocompatibility, has balanced climbing and covering of an EC layer while keeping the support force of the stent, inhibits restenosis, and recovers tissues, especially the self performance of a blood vessel at the right moment.

Description

Background technique [0001] The invention belongs to the field of medical materials, and relates to a prosthetic material, in particular, a biocompatible stent material, more suitable for intravascular stent materials. [0002] The body includes various passages, such as arteries, other blood vessels, and other body lumens. Sometimes these channels become blocked or weakened. For example, a channel can be blocked by a tumor, narrowed by a plaque, or weakened by an aneurysm. When these conditions occur, the channel can be reopened or enhanced, or even replaced, using a medical endoprosthesis. An endoprosthesis is typically a tubular member that is placed in a lumen in the body. Examples of endoprostheses include stents, covered prostheses, stent grafts and vessel closure pins. [0003] Stents (stents, stents), venous filters, expandable frames and similar implantable medical devices, hereinafter collectively referred to as stents, are radially expandable internal prostheses...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61L31/14A61L31/16A61L31/04
CPCA61L31/047A61L31/145A61L31/148A61L31/16A61L2300/102A61L2300/416A61L2300/604A61L2300/622C08L89/00
Inventor 李鸣涛邓焯键石佳明
Owner CHINABRIDGE (SHENZHEN) MEDICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products